Mobile in Clinical Trials Europe - May 15-16, 2018 - London, UK London, England, UK 15-16 May 2018

Description:
Led by Chair Dr Daniel Karlin of Pfizer, Mobile in Clinical Trials Europe opens with a session given by Tilo Hache, Novartis, on the factors that must be addressed to implement mobile tools in the fragmented European landscape and to meet the needs of regulators and patients. Additional sessions:

- Roche's Dr Christian Gossens discusses digital biomarker measures and how to implement and scale up mobile technology in Parkinson's disease and Multiple Sclerosis.

URLs:
Booking: https://go.evvnt.com/200032-0?pid=4440
Inquiries: https://go.evvnt.com/200032-2?pid=4440

Time: 8:00 am to 6:00 pm

Price:
Standard Pricing: USD 2094

Speakers: Emma Bender, Marketing Manager, NIHR Jennifer Goldsack, MChem, MA, MBA, CPHQ, Clinical Project Manager, CTTI Christian Gossens, PhD, MBA, Global Head Early Development Workflows, pRED, Informatics, Roche Pharmaceutical Research and Early Development (pRED) Tilo Hache, MBA, Digital Endpoint Strategy Lead, Novartis Bert Hartog, PhD, Senior Director, Clinical Innovation, RandD Operations, Janssen Daniel Karlin, MD, Head of Experimental Medicine, Informatics and Regulatory Strategy, Pfizer Innovation Research Lab, Pfizer Inc. Carol Maguire, RN, Director of Clinical Research, Division of Cardiology, UCSF Nuria Oliver, PhD, Director of Research in Data Science, Vodafone Tushar Parlikar, PhD, Product Manager, Verily Life Sciences Barry Pinnington, Patient Advocate Hilde Vanaken, PhD, Director, RandD Operations Innovation, Janssen